Options: Show MedDRA Preferred Terms
Side effect | Data for drug | Placebo | Labels | |||
---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | |||
Pruritus | common | x | x | x | x | |
Cushing's syndrome | very rare | x | ||||
Hypersensitivity | very rare | x | ||||
Skin striae | very rare | x | x | x | x | |
Endocrine disorder | x | |||||
Folliculitis | x | x | x | |||
Hypertrichosis | x | x | x | x | ||
Immune system disorder | x | |||||
Miliaria | x | x | x | |||
Telangiectasia | x | x | ||||
Erythema | x | x | ||||
Skin atrophy | x | x | x | |||
Pustular psoriasis | x | |||||
Allergic contact dermatitis | x | x | x | x | ||
Leukoderma | x | x | x | |||
Acneiform eruption | x | x | x | |||
Unspecified disorder of skin and subcutaneous tissue | x | |||||
Rash follicular | x | x | ||||
Dermatitis perioral | x | x | x | |||
Secondary infection | x | x | x | |||
Tingling sensation | x | x |
Information about indications was extracted from the indications and usage sections of the labels.
standard – alternative
100% | ||
75% | ||
50% | ||
10% | ||
frequent (1% to 100%) | ||
infrequent (0.1% to 1%) | ||
rare (<0.1%) | ||
postmarketing | ||
0% | ||
no frequency information | ||
not found on label |